Bio LIMS INC attends 26th ASGCT(the American Society of Gene and Cell Therapy)
[Los Angeles, 05/2023] - The 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) for the year 2023 concluded on a high note, bringing together leading experts and professionals in the field of gene and cell therapy from around the world. The event provided a platform for numerous global companies specializing in gene and cell therapy to showcase their latest research developments, spanning cutting-edge therapies such as gene-edited TIL therapy, gene replacement therapy, in vivo RNA editing, among others. Many of these studies were presented through oral presentations, demonstrating the rapid progress in the field.
Among the notable participants was Bio LIMS INC, a global provider of precision medicine and innovative biopharmaceutical digital solutions. Bio LIMS INC showcased its commitment to advancing the field of gene and cell therapy through the unveiling of four international digital systems: Bio-CELL, Bio-LIMS, Bio-Research, and Bio-Bank. These platforms are poised to play a pivotal role in digitizing and streamlining various aspects of cell and gene therapy research and development. With this significant leap, Bio LIMS INC is even more confident in its strategic expansion into the North American market.
Mr. Ni Yi, the representative of Bio LIMS INC, was present at the conference, engaging in fruitful discussions and exchanges with fellow attendees and partners. His participation further underscored the commitment of Bio LIMS INC to foster collaboration and drive advancements in the field of gene and cell therapy.
The ASGCT Annual Meeting continues to be a catalyst for innovation and collaboration in the rapidly evolving field of gene and cell therapy, solidifying its position as a global leader in advancing healthcare solutions.
For more information about ASGCT and future events, please visit ASGCT Website.